The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

A novel HSP90 inhibitor SL-145 suppresses metastatic triple

Articles in 2021 Cell Death Discovery

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

HSP90 inhibitors induce GPNMB cell-surface expression by

Generation and characterization of cellular models expressing

Pan- and isoform-specific inhibition of Hsp90: Design strategy and

Pan- and isoform-specific inhibition of Hsp90: Design strategy and

β-Escin overcomes trastuzumab resistance in HER2-positive breast

PDF) A novel HSP90 inhibitor SL-145 suppresses metastatic triple

Soeun Park's research works Korea University, Seoul (KU) and

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab

PDF) A novel HSP90 inhibitor targeting the C-terminal domain

Following the design path of isoform-selective Hsp90 inhibitors